| ACS | American Cancer Society |
| AMPK | Adenosine Monophosphate-activated Protein Kinase |
| ARSI | Androgen Receptor Signaling Inhibitor |
| BCRT | Breast Cancer C-terminal Domains |
| CSC | Cancer Stem Cell |
| CAR | Chimeric Antigen Receptor |
| COX | Cyclooxygenase |
| CPZ | Chlorpromazine |
| DDP | Diamminedichloroplatinum |
| DHFR | Dihydrofolate Reductase |
| DOX | Doxorubicin |
| ER | Estrogen Receptor |
| FLICE | FADD-like IL-1β-converting Enzyme |
| HER2 | Human Epidermal growth factor Receptor-related protein (HER2) |
| HIF | Hypoxia-inducible Factor |
| IAPs | Inhibitors of Apoptosis Proteins |
| iDNMT | DNA Methylation Inhibitors |
| IHC | Immunohistochemical |
| iHDACs | Histone Deacetylase Inhibitors |
| JNK | Jun N-terminal Kinase |
| MBZ | Mebendazole |
| MDM2 | Murine Double Minute 2 |
| MDR | Multidrug Resistance |
| MRP | Multidrug Resistance Protein |
| MTX | Methotrexate |
| PEI | Polyethyleneimine |
| PEO | Polyethylene Oxide |
| PET | Positron Emission Tomography |
| PHD | Prolyl Hydroxylase Domain |
| PLGA | Poly lactic-co-glycolic acid |
| PR | Progesterone Receptor |
| PTM | Posttranscriptional Modifications |
| RCC | Renal Cell Carcinoma |
| RES | Reticuloendothelial system |
| RFC | Reduced Folate Carrier |
| TAM | Tumor-associated Macrophages |
| TCTP | Translationally Controlled Tumor Protein |
| TME | Tumor Microenvironment |
| TRAIL | Tumor necrosis factor-Related Apoptosis-Inducing Ligand |
| TS | Thymidylate Synthase |
| VEGF | Vascular Endothelial Growth Factor |